Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1/2 Study to Evaluate the Safety and Efficacy of AGN-193408 SR in Participants With Open-Angle Glaucoma or Ocular Hypertension

NCT04499248 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT04499248
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04499248 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1/2 Study to Evaluate the Safety and Efficacy of AGN-193408 SR in Participants With Open-Angle Glaucoma or Ocular Hypertension
Lead sponsor
AbbVie
Phase
Phase 1/2
Overall status
Active, not recruiting
Start date
November 16, 2020
Completion date
April 30, 2029
Enrollment
100 (actual)
Sites
49

Conditions

As the registry lists them; a condition with its own page is linked.

ocular hypertension, open-angle glaucoma